The Cytotoxic Activity of Bacillus Anthracis Lethal Factor is Inhibited by Leukotriene A4 Hydrolase and Metallopeptidase Inhibitors

Overview

Journal Biochem J

Specialty Biochemistry

Date 1996 Dec 1

PMID 8973585

Citations 6

Authors

A Menard

E Papini

M Mock

C Montecucco

Affiliations

Soon will be listed here.

Abstract

The lethal factor of Bacillus anthracis is central to the pathogenesis of anthrax. Its mechanism of action is still unknown. Recently, on the basis of sequence similarities, we suggested that lethal factor might act similarly to leukotriene A4 hydrolase (LTA4), a bifunctional enzyme also endowed with a metallopeptidase activity. Here we show that some inhibitors of the LTA4 hydrolase and metallopeptidase activities of LTA4 hydrolase also affect the cytotoxicity of the anthrax lethal factor on macrophage cell lines, without interfering with the ability of the lethal factor to enter cells. These results support the proposal that anthrax lethal factor might display in the cytosol of intoxicated cells a peptidase activity similar to that of LTA4 hydrolase.

Citing Articles

Profiling lethal factor interacting proteins from human stomach using T7 phage display screening.

Cardona-Correa A, Rios-Velazquez C Mol Med Rep. 2016; 13(5):3797-804.

PMID: 27035230 PMC: 4838128. DOI: 10.3892/mmr.2016.5031.

Designed azolopyridinium salts block protective antigen pores in vitro and protect cells from anthrax toxin.

Beitzinger C, Bronnhuber A, Duscha K, Riedl Z, Huber-Lang M, Benz R PLoS One. 2013; 8(6):e66099.

PMID: 23840407 PMC: 3688708. DOI: 10.1371/journal.pone.0066099.

High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.

Pelat T, Hust M, Laffly E, Condemine F, Bottex C, Vidal D Antimicrob Agents Chemother. 2007; 51(8):2758-64.

PMID: 17517846 PMC: 1932538. DOI: 10.1128/AAC.01528-06.

Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Barth H, Aktories K, Popoff M, Stiles B Microbiol Mol Biol Rev. 2004; 68(3):373-402, table of contents.

PMID: 15353562 PMC: 515256. DOI: 10.1128/MMBR.68.3.373-402.2004.

Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C Biochem J. 2000; 352 Pt 3:739-45.

PMID: 11104681 PMC: 1221512.

References

Wallace J, Macnaughton W, Morris G, Beck P . Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989; 96(1):29-36. DOI: 10.1016/0016-5085(89)90760-9. View

Lecomte J, Costentin J, Vlaiculescu A, Chaillet P, Llorens-Cortes C, Leboyer M . Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. J Pharmacol Exp Ther. 1986; 237(3):937-44. View

Hansen M, Nielsen S, Berg K . Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989; 119(2):203-10. DOI: 10.1016/0022-1759(89)90397-9. View

Gillard J, Ford-Hutchinson A, Chan C, Charleson S, Denis D, Foster A . L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 1989; 67(5):456-64. DOI: 10.1139/y89-073. View

Samuelsson B, Funk C . Enzymes involved in the biosynthesis of leukotriene B4. J Biol Chem. 1989; 264(33):19469-72. View

Rouzer C, Ford-Hutchinson A, MORTON H, Gillard J . MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J Biol Chem. 1990; 265(3):1436-42. View

Dixon R, Diehl R, Opas E, Rands E, Vickers P, Evans J . Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990; 343(6255):282-4. DOI: 10.1038/343282a0. View

Orning L, Krivi G, Fitzpatrick F . Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. J Biol Chem. 1991; 266(3):1375-8. View

Medina J, WETTERHOLM A, Radmark O, Shapiro R, Haeggstrom J, Vallee B . Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis. Proc Natl Acad Sci U S A. 1991; 88(17):7620-4. PMC: 52353. DOI: 10.1073/pnas.88.17.7620. View

10.

Orning L, Krivi G, Bild G, Gierse J, Aykent S, Fitzpatrick F . Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril. J Biol Chem. 1991; 266(25):16507-11. View

11.

Evans J, Kargman S . Bestatin inhibits covalent coupling of [3H]LTA4 to human leukocyte LTA4 hydrolase. FEBS Lett. 1992; 297(1-2):139-42. DOI: 10.1016/0014-5793(92)80345-h. View

12.

Labaudiniere R, Hilboll G, Lautenschlager H, Parnham M, Kuhl P, Dereu N . Omega-[(omega-arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors. J Med Chem. 1992; 35(17):3156-69. DOI: 10.1021/jm00095a010. View

13.

WETTERHOLM A, Medina J, Radmark O, Shapiro R, Haeggstrom J, Vallee B . Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296. Proc Natl Acad Sci U S A. 1992; 89(19):9141-5. PMC: 50081. DOI: 10.1073/pnas.89.19.9141. View

14.

Labaudiniere R, Hendel W, Terlain B, Cavy F, Marquis O, Dereu N . omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. J Med Chem. 1992; 35(23):4306-14. DOI: 10.1021/jm00101a007. View

15.

Kitabgi P, Dubuc I, Nouel D, Costentin J, Cuber J, Fulcrand H . Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus. Neurosci Lett. 1992; 142(2):200-4. DOI: 10.1016/0304-3940(92)90373-f. View

16.

Hanna P, Kochi S, Collier R . Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell. 1992; 3(11):1269-77. PMC: 275693. DOI: 10.1091/mbc.3.11.1269. View

17.

Tronrud D, Roderick S, Matthews B . Structural basis for the action of thermolysin. Matrix Suppl. 1992; 1:107-11. View

18.

Yuan W, Munoz B, Wong C, Haeggstrom J, WETTERHOLM A, Samuelsson B . Development of selective tight-binding inhibitors of leukotriene A4 hydrolase. J Med Chem. 1993; 36(2):211-20. DOI: 10.1021/jm00054a004. View

19.

Hanna P, Acosta D, Collier R . On the role of macrophages in anthrax. Proc Natl Acad Sci U S A. 1993; 90(21):10198-201. PMC: 47741. DOI: 10.1073/pnas.90.21.10198. View

20.

Pezard C, Duflot E, Mock M . Construction of Bacillus anthracis mutant strains producing a single toxin component. J Gen Microbiol. 1993; 139(10):2459-63. DOI: 10.1099/00221287-139-10-2459. View